International Psoriasis Council

Chapters

Opening
Introduction
Chapter 1
The Evolution of the Clinical Trials Process - A Brief History Lesson
Chapter 2
It Takes a Village to Conduct a Clinical Trial
Chapter 3
Not All Clinical Trials are Created Equal - Understanding the Different Phases
Chapter 4
There's No Going Outside the Lines - Ethical Considerations in the Conduct of Clinical Trials
Chapter 5
What You Need to Know to Live in Harmony with Your Institutional Review Board and Research Ethics Committee
Chapter 6
Be Informed About Informed Consent
Chapter 7
Practical Advice for Following Good Clinical Practice
Chapter 8
Living in a Material World - What is Needed to Run a Successful Clinical Trial
Chapter 9
Clinical Trial Coordinators - A Vital Sign of a Good Clinical Trial
Chapter 10
The Subject of Recruitment and Retention
Chapter 11
The Investigational Compound - Like Handling Kryptonite
Chapter 12
Budgets and Contracts - Show Me the Money
Chapter 13
Everything You Write Can Be Used Against You in a Court of Law - Understanding Proper Documentation
Chapter 14
Audits/Inspections - Be Prepared for Anything
Chapter 15
Conducting Clinical Trials Without Ending Up on Trial

Legal Bios

Jeffrey Fine

Jeffrey E. Fine’s blend of intellectual property and corporate finance and transactional experience is particularly valuable in light of the proliferation of transactions involving intellectual property assets and venture capital, securities, structured finance, conventional loans and other capital sources. Counseling and representing hundreds of clients, Mr. Fine works to protect and preserve their business identity, which includes trademarks, service marks, trade dress, trade secrets, copyrights and digital assets. He has extensive experience in negotiating and documenting computer technology transfers and issues arising out of electronic commerce. Mr. Fine’s corporate finance and mergers and acquisitions experience is extensive. As bond counsel for the City of St. Louis, Mr. Fine worked on the public sale of tax-exempt bonds to finance the new Kiel Center Sports Arena. As counsel in various capacities, Mr. Fine handled over $300 million in tax-exempt securities offerings.